Hematopoietic repopulating ability of CD34+ progenitor cells ex vivo expanded with different cytokine combinations

被引:7
|
作者
Du, Zheng [1 ]
Jin, Huili [1 ]
Cai, Haibo [1 ]
Yang, Shi [1 ]
Tan, Wen-song [1 ]
机构
[1] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Sch Bioengn, Shanghai 200237, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
CD34(+) cells; cytokine combination; hematopoietic repopulating ability; multi-lineage reconstitution; NOD/SCID mice; UMBILICAL-CORD BLOOD; NOD/SCID MICE; FLK2/FLT3; LIGAND; BONE-MARROW; STEM-CELLS; EXPANSION; ENGRAFTMENT; RECONSTITUTION; TRANSPLANTATION; THROMBOPOIETIN;
D O I
10.3109/21691401.2014.897630
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Ex-vivo expansion technologies were developed for application of hematopoietic stem cells (HSCs) derived from cord blood (CB). The cytokine combination was essential to expand HSCs ex vivo and maintain the function of expanded HSCs. However the optimal cytokine combination was not determined. In this study, two combinations of cytokines were applied in ex-vivo expansion of HSCs to investigate the effect on the hematopoietic repopulating ability of expanded HSCs. CB CD34(+) cells were expanded with SCF + TPO + FL (STF) or SCF + TPO + FL + IL-3 + IL-6 (STF36) for 7 days and got 30.3 +/- 6.4 and 39.8 +/- 7.3 folds of total cells, respectively. The cells cultured by both STF and STF36 could engraft and repopulate in nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice effectively; however, the STF group achieved higher level of engraftment. These result demonstrated that the cytokine combination of STF36 favored the expansion of cells, while the cytokine combination of STF facilitated the engraftment and multi-lineage repopulating in vivo. These findings may have important implications for the cell therapy.
引用
收藏
页码:398 / 402
页数:5
相关论文
共 50 条
  • [31] Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells
    Delalat, Bahman
    Pourfathollah, Ali Akbar
    Soleimani, Masoud
    Mozdarani, Hossein
    Ghaemi, Soraya Rasi
    Movassaghpour, Ali Akbar
    Kaviani, Saeed
    HEMATOLOGY, 2009, 14 (03) : 125 - 132
  • [32] Ex vivo differentiation of natural killer cells from human umbilical cord blood CD34+ progenitor cells
    Pinho, Maria Joao
    Punzel, Michael
    Sousa, Mario
    Barros, Alberto
    CELL COMMUNICATION AND ADHESION, 2011, 18 (03) : 45 - 55
  • [33] Cytokine combinations on the potential for ex vivo expansion of murine hematopoietic stem cells
    Lui, Wing Chi
    Chan, Yuen Fan
    Chan, Li Chong
    Ng, Ray Kit
    CYTOKINE, 2014, 68 (02) : 127 - 132
  • [34] CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells
    Murray, LJ
    Bruno, E
    Uchida, N
    Hoffman, R
    Nayar, R
    Yeo, EL
    Schuh, AC
    Sutherland, DR
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (08) : 1282 - 1294
  • [35] Stem cell factor is essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded cord blood CD34+ cells
    Du, Zheng
    Wang, Ziyan
    Zhang, Weiwei
    Cai, Haibo
    Tan, Wen-Song
    CELL PROLIFERATION, 2015, 48 (03) : 293 - 300
  • [36] CD34+ Circulating Progenitor Cells after Different Training Programs
    Nino, O.
    Balague, N.
    Aragones, D.
    Blasi, J.
    Alamo, J. M.
    Corral, L.
    Javierre, C.
    Miguel, M.
    Viscor, G.
    Ventura, J. L.
    INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 2015, 36 (04) : 292 - 296
  • [37] Angptl4 maintains in vivo repopulation capacity of CD34+ human cord blood cells
    Blank, Ulrika
    Ehrnstroem, Birgitta
    Heinz, Niels
    Nilsson, Eva
    Brun, Ann
    Baum, Christopher
    Schiedlmeier, Bernhard
    Karlsson, Stefan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (03) : 198 - 205
  • [38] Ex vivo large-scale generation of human platelets from cord blood CD34+ cells
    Matsunaga, Takuya
    Tanaka, Ikuta
    Kobune, Masayoshi
    Kawano, Yutaka
    Tanaka, Maki
    Kuribayashi, Kageaki
    Iyama, Satoshi
    Sato, Tsutomu
    Sato, Yasushi
    Takimoto, Rishu
    Takayama, Tetsuji
    Kato, Junji
    Ninomiya, Takafumi
    Hamada, Hirofumi
    Niitsu, Yoshiro
    STEM CELLS, 2006, 24 (12) : 2877 - 2887
  • [39] Gene expression profile of megakaryocytes from human cord blood CD34+ cells ex vivo expanded by thrombopoietin
    Kim, JA
    Jung, YJ
    Seoh, JY
    Woo, SY
    Seo, JS
    Kim, HL
    STEM CELLS, 2002, 20 (05) : 402 - 416
  • [40] Clinical applications of ex vivo cultured CD34+ cells and myeloid progenitors
    Zimmerman, TM
    Williams, SF
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1998, 4 (04) : 257 - 264